A pair of high-volume orthopedic surgeons say they're skeptical of so-called 'repless' sales models such as Smith & Nephew's Syncera offering.
A pair of high-volume orthopedists who specialize in hip and knee replacement surgeries are skeptical of generic or "repless" sales models, in which medical device companies offer lower-cost implants without a sales rep on hand to advise during the procedure.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BU0hby
Cap comentari:
Publica un comentari a l'entrada